TY - JOUR
T1 - Added value of Joint ENT-Rheumatology clinic in the management of ANCA-associated vasculitis
T2 - One year's experience
AU - Stavrakas, M.
AU - Smith, R.
AU - Akil, M.
AU - Kuet, K. P.
AU - Morley, F.
AU - Ray, J.
N1 - Publisher Copyright:
© 2021
PY - 2022/7/1
Y1 - 2022/7/1
N2 - Purpose: ANCA-associated vasculitides (AAV) represent a group of diagnoses, including granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA) and microscopic polyangiitis (MPA). Most commonly, they present initially with ENT-associated symptomatology, and therefore they often pose a diagnostic challenge. We aim to present our one-year experience in the joint management of AAV in a multi-disciplinary setting. Methods: We performed a retrospective analysis based on the records of 39 patients who were seen in the joint clinic, during a period of one year. Results: After clinical assessment, 13 patients had changes made to their ENT treatment, 2 had some changes in their immunosuppression, while 11 had changes in both ENT and Rheumatology treatment. Six patients did not require any alterations to their therapeutic scheme. On average three separate appointments were reduced to a single appointment in the joint clinic where definitive treatment decisions were made. This led to significant cost reductions. Conclusions: Cost-effectiveness, patient satisfaction, rapid multi-disciplinary evaluation, avoidance of unnecessary immunosuppression, patient education and medical training are only a few of the many advantages of this proposed joint service.
AB - Purpose: ANCA-associated vasculitides (AAV) represent a group of diagnoses, including granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA) and microscopic polyangiitis (MPA). Most commonly, they present initially with ENT-associated symptomatology, and therefore they often pose a diagnostic challenge. We aim to present our one-year experience in the joint management of AAV in a multi-disciplinary setting. Methods: We performed a retrospective analysis based on the records of 39 patients who were seen in the joint clinic, during a period of one year. Results: After clinical assessment, 13 patients had changes made to their ENT treatment, 2 had some changes in their immunosuppression, while 11 had changes in both ENT and Rheumatology treatment. Six patients did not require any alterations to their therapeutic scheme. On average three separate appointments were reduced to a single appointment in the joint clinic where definitive treatment decisions were made. This led to significant cost reductions. Conclusions: Cost-effectiveness, patient satisfaction, rapid multi-disciplinary evaluation, avoidance of unnecessary immunosuppression, patient education and medical training are only a few of the many advantages of this proposed joint service.
KW - EGPA
KW - ENT
KW - GPA
KW - Otolaryngology
KW - Rheumatology
KW - Vasculitis
UR - http://www.scopus.com/inward/record.url?scp=85129958653&partnerID=8YFLogxK
U2 - 10.1016/j.amjoto.2022.103485
DO - 10.1016/j.amjoto.2022.103485
M3 - Article
C2 - 35567837
AN - SCOPUS:85129958653
SN - 0196-0709
VL - 43
JO - American Journal of Otolaryngology - Head and Neck Medicine and Surgery
JF - American Journal of Otolaryngology - Head and Neck Medicine and Surgery
IS - 4
M1 - 103485
ER -